Product
15-valent pneumococcal conjugate vaccine
2 clinical trials
3 indications
Indication
Healthy Control ParticipantsIndication
Pneumococcal VaccinesIndication
Immune suppressionClinical trial
Clinical Study on the Consistency of 15-valent Pneumococcal Conjugate Vaccine in Three Batches of 3-month-old Population and the Immunogenicity and Safety of Vaccination in 7-5-year-old PopulationStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly VeteransStatus: Not yet recruiting, Estimated PCD: 2024-08-01